HUMACYTE ANNOUNCES PHASE 3 V012 TRIAL RESULTS FOR ATEV IN WOMEN REQUIRING HEMODIALYSIS ACCESS ACCEPTED FOR A LATE-BREAKING SESSION PRESENTATION AT ASN KIDNEY WEEK 2026

Reuters · 3d ago

Please log in to view news